PRX-PLUS has a unique product feature with its deep-impacting formula
A significant proportion of healthcare professionals still tend to favor branded drugs
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
The company increases its efficiency and is able to face the growing demand for its services.
Subscribe To Our Newsletter & Stay Updated